Breaking News

Icon Bioscience Appoints Clinical Development VP

Dr. Murahashi joins the management team

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Icon Bioscience, Inc. (IBI) has appointed Wendy Yee Murahashi, M.D. as vice president of Clinical Development. Dr. Murahashi will lead the company’s clinical development programs based on IBI’s Verisome drug delivery technology.   “As we near the completion of our pivotal Phase II/III trial evaluating IBI-10090 for the treatment of inflammation in patients undergoing cataract surgery, Wendy brings to IBI relevant clinical experience that will provide immediate value to IBI,” said William S. Whit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters